First of all, please note that Genmab is listed both on the Nasdaq and on the Copenhagen Stock Exchange. In the U.S., is possible to invest in Genmab's American depositary receipts, which have a conversion ratio of 10 ADRs for each (Danish) ordinary share. This is important to avoid confusion when converting items or metrics taken from the original company financial statements to the U.S. stock-related ones.